The outlook for GLP-1s at JPM 2025 is more complicated
Peptide Therapy BPC-157 vs TB-500 compared on mechanism, evidence quality, dosing, and real failure modes
Eli Lilly, the maker of Zepbound, announced Tuesday it will begin selling the weight loss drug directly to consumers through the company's direct pharmacy, LillyDirect
Alison Cave, the MHRAs Chief Safety Officer, underscores the importance of patient safety and encourages both patients and healthcare professionals to report any sudden loss of vision or other adverse reactions through the Yellow Card scheme
At least one in three patients has had a pigmented macule in the area for some time before the melanoma was diagnosed, sometimes for years
This is often a sign that the body is adjusting to a higher level of nutrient intake